Live Breaking News & Updates on Michaels Ip

Stay updated with breaking news from Michaels ip. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Three studies affirm efficacy, safety of brolucizumab in DME

WAIKOLOA, Hawaii — Brolucizumab 6 mg demonstrates a favorable benefit-risk profile in the treatment of patients with diabetic macular edema, according to a presentation at Retina 2022.“To conclude on the summary of all three of these clinical trials, brolucizumab 6 mg was noninferior to aflibercept in respect to visual acuity at week 52 with fewer injections in the KESTREL and KITE ....

United States , Byerich Martin , Michaels Ip ,